To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With

Updated 06/21/2024

Status Terminated

Clinical Trial Summary

This study is designated to evaluate the safety and efficacy of Sunpharma1505 in subjects with active rheumatoid arthritis who are experiencing a flare/exacerbation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02534896
Study type	Interventional
Source	Sun Pharmaceutical Industries Limited
Contact
Status	Terminated
Phase	Phase 3
Start date	November 2015
Completion date	June 2018

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04472481` - Vitamin D Effect in Rheumatoid Arthritis.	Phase 4
	Completed	`NCT00959036` - Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis	Phase 1/Phase 2
	Completed	`NCT00913458` - Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis	Phase 4
	Completed	`NCT01961505` - Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis	N/A
	Completed	`NCT00393471` - Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.	Phase 3
	Not yet recruiting	`NCT03346590` - Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects	N/A
	Completed	`NCT03172325` - Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA	Phase 3
	Completed	`NCT00420199` - A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate	Phase 3
	Recruiting	`NCT06456489` - Pulse Steroid Injection in Refractory Rheumatoid Arthritis	Phase 3
	Completed	`NCT00882024` - Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)	Phase 2
	Completed	`NCT03599986` - Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis
	Completed	`NCT02586246` - Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870	Phase 3
	Completed	`NCT01008852` - Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis	Phase 2